Synopsis
0
KDMF
0
VMF
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Topical
Parenteral
Solubilizers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
89
PharmaCompass offers a list of Fluphenazine Deconate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fluphenazine Deconate manufacturer or Fluphenazine Deconate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fluphenazine Deconate manufacturer or Fluphenazine Deconate supplier.
PharmaCompass also assists you with knowing the Fluphenazine Deconate API Price utilized in the formulation of products. Fluphenazine Deconate API Price is not always fixed or binding as the Fluphenazine Deconate Price is obtained through a variety of data sources. The Fluphenazine Deconate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Prolixin decanoate (TN) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Prolixin decanoate (TN), including repackagers and relabelers. The FDA regulates Prolixin decanoate (TN) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Prolixin decanoate (TN) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Prolixin decanoate (TN) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Prolixin decanoate (TN) supplier is an individual or a company that provides Prolixin decanoate (TN) active pharmaceutical ingredient (API) or Prolixin decanoate (TN) finished formulations upon request. The Prolixin decanoate (TN) suppliers may include Prolixin decanoate (TN) API manufacturers, exporters, distributors and traders.
click here to find a list of Prolixin decanoate (TN) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Prolixin decanoate (TN) DMF (Drug Master File) is a document detailing the whole manufacturing process of Prolixin decanoate (TN) active pharmaceutical ingredient (API) in detail. Different forms of Prolixin decanoate (TN) DMFs exist exist since differing nations have different regulations, such as Prolixin decanoate (TN) USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Prolixin decanoate (TN) DMF submitted to regulatory agencies in the US is known as a USDMF. Prolixin decanoate (TN) USDMF includes data on Prolixin decanoate (TN)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Prolixin decanoate (TN) USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Prolixin decanoate (TN) suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Prolixin decanoate (TN) Drug Master File in Japan (Prolixin decanoate (TN) JDMF) empowers Prolixin decanoate (TN) API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Prolixin decanoate (TN) JDMF during the approval evaluation for pharmaceutical products. At the time of Prolixin decanoate (TN) JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Prolixin decanoate (TN) suppliers with JDMF on PharmaCompass.
A Prolixin decanoate (TN) CEP of the European Pharmacopoeia monograph is often referred to as a Prolixin decanoate (TN) Certificate of Suitability (COS). The purpose of a Prolixin decanoate (TN) CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Prolixin decanoate (TN) EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Prolixin decanoate (TN) to their clients by showing that a Prolixin decanoate (TN) CEP has been issued for it. The manufacturer submits a Prolixin decanoate (TN) CEP (COS) as part of the market authorization procedure, and it takes on the role of a Prolixin decanoate (TN) CEP holder for the record. Additionally, the data presented in the Prolixin decanoate (TN) CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Prolixin decanoate (TN) DMF.
A Prolixin decanoate (TN) CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Prolixin decanoate (TN) CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Prolixin decanoate (TN) suppliers with CEP (COS) on PharmaCompass.
A Prolixin decanoate (TN) written confirmation (Prolixin decanoate (TN) WC) is an official document issued by a regulatory agency to a Prolixin decanoate (TN) manufacturer, verifying that the manufacturing facility of a Prolixin decanoate (TN) active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Prolixin decanoate (TN) APIs or Prolixin decanoate (TN) finished pharmaceutical products to another nation, regulatory agencies frequently require a Prolixin decanoate (TN) WC (written confirmation) as part of the regulatory process.
click here to find a list of Prolixin decanoate (TN) suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Prolixin decanoate (TN) as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Prolixin decanoate (TN) API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Prolixin decanoate (TN) as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Prolixin decanoate (TN) and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Prolixin decanoate (TN) NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Prolixin decanoate (TN) suppliers with NDC on PharmaCompass.
Prolixin decanoate (TN) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Prolixin decanoate (TN) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Prolixin decanoate (TN) GMP manufacturer or Prolixin decanoate (TN) GMP API supplier for your needs.
A Prolixin decanoate (TN) CoA (Certificate of Analysis) is a formal document that attests to Prolixin decanoate (TN)'s compliance with Prolixin decanoate (TN) specifications and serves as a tool for batch-level quality control.
Prolixin decanoate (TN) CoA mostly includes findings from lab analyses of a specific batch. For each Prolixin decanoate (TN) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Prolixin decanoate (TN) may be tested according to a variety of international standards, such as European Pharmacopoeia (Prolixin decanoate (TN) EP), Prolixin decanoate (TN) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Prolixin decanoate (TN) USP).
